INTEGRA LIFESCIENCES HOLDINGS CORP Expense Breakdown
No Expense Breakdown for IART on this site yet.
- 2026-06-30: Specialty Surgery $130.21M; Tissue Reconstruction $41.99M.
- 2025-06-30: Specialty Surgery $120.24M; Tissue Reconstruction $56.66M.
Source checked: the stored Expense Breakdown page for IART.
Expenses by product
Cost of sales: each quarter (3 month)
| Quarter end | Specialty Surgery | Tissue Reconstruction |
|---|
| 2026-06-30 | $130.21M | $41.99M |
|---|
| 2025-06-30 | $120.24M | $56.66M |
|---|
Costs and Expenses: each quarter (3 month)
| Quarter end | Specialty Surgery | Tissue Reconstruction |
|---|
| 2026-06-30 | $220.40M | $90.55M |
|---|
| 2025-06-30 | $606.15M | $231.00M |
|---|
Research and Development Expense (Excluding Acquired in Process Cost): each quarter (3 month)
| Quarter end | Specialty Surgery | Tissue Reconstruction |
|---|
| 2026-06-30 | $14.20M | $8.17M |
|---|
| 2025-06-30 | $14.63M | $6.77M |
|---|
Selling, General and Administrative Expense: each quarter (3 month)
| Quarter end | Specialty Surgery | Tissue Reconstruction |
|---|
| 2026-06-30 | $75.98M | $40.39M |
|---|
| 2025-06-30 | $83.17M | $44.31M |
|---|